The Influence of Hepatic and Renal Impairment on the Pharmacokinetics of a Treatment for Herpes Zoster, Amenamevir (ASP2151): Phase 1, Open-Label, Single-Dose, Parallel-Group Studies Author Name Tomohiro Kusawake et al Category Computer science, information & general works Type Journal Tags Amenamevir,Hepatic impairment,herpes zoster,Pharmacokinetics,Renal impairment,safety Login to Access Content
